Description

Cinnarizin (Cinnarizinum) forte 0.075 №20

Ingredients

Active ingredient: Cinnarizine 75mg per tablet.

Dosage

Recommended dosage: 1 tablet daily, or as directed by a healthcare professional.

Indications

Cinnarizin forte 0.075 №20 is indicated for the treatment of vertigo, motion sickness, and symptoms of Meniere’s disease.

Contraindications

Do not use Cinnarizin forte 0.075 №20 if you are allergic to cinnarizine or any other ingredients in the product.

Directions

Take the tablet with a glass of water, preferably after a meal to reduce stomach upset.

Scientific Evidence

Cinnarizine, the active ingredient in Cinnarizin forte 0.075 №20, is a calcium channel blocker with antihistaminic properties. It is known to improve cerebral blood flow and reduce the sensitivity of the vestibular system, thus alleviating symptoms of vertigo and motion sickness.

Several studies have demonstrated the efficacy of cinnarizine in managing vertigo and Meniere’s disease. A study published in the journal Clinical Otolaryngology showed that cinnarizine significantly reduced the frequency and severity of vertigo attacks in patients with Meniere’s disease.

Additional Information

Cinnarizin forte 0.075 №20 is well-tolerated by most individuals; however, some common side effects may include drowsiness, dry mouth, and gastrointestinal disturbances. It is important to avoid driving or operating heavy machinery until you know how this medication affects you.

Consult your healthcare provider before using Cinnarizin forte 0.075 №20, especially if you have a history of cardiovascular diseases or are taking other medications.